RxDoctor Payments Data

Ricardo Martinez, MD

Family Medicine · Farmers Branch, TXNPI 1255472999

Payments from drug & device makers

$7,710in general payments, 2019–2025

Across 336 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$1K
  • Bayer$1K
  • AstraZeneca$981
  • Medtronic$659
  • Boehringer Ingelheim$538
  • Amgen$474
  • plus $3K from 39 others

What the payments were for

  • Travel & lodging$3895%
  • Food & beverage$7,28194%
  • Education$411%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,710 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$13,429,451
Medicare patients
206
Services billed
10,412

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide41$72,318
JardianceEmpagliflozin30$47,441
Synjardy XrEmpagliflozin/Metformin Hcl29$41,171
EliquisApixaban25$35,157
SantylCollagenase Clostridium Hist.19$24,150
RybelsusSemaglutide14$21,405
FarxigaDapagliflozin Propanediol16$20,177
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$16,697
Janumet XrSitagliptin Phos/Metformin Hcl12$15,845
JanumetSitagliptin Phos/Metformin Hcl11$14,610
VascepaIcosapent Ethyl15$6,530
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen135$3,627
Epinephrine13$2,725
Omeprazole76$1,475
Gabapentin59$1,453

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$269$93,72355 claims
Boehringer IngelheimJardiance, Synjardy Xr$538$88,61259 claims
PfizerEliquis$74$35,15725 claims
MerckJanumet Xr, Janumet$143$30,45423 claims
Smith+NephewSantyl$28$24,15019 claims
AstraZenecaFarxiga$981$20,17716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Farmers Branch

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →